Mr. Batcheller is a corporate/commercial lawyer focused on pharmaceutical, biotech and medical device clients and is actively involved in managing and advising pharmaceutical and biotech start-ups in the Öresund region. He obtained his LL.M. in European Law at Lund University, his B.Sc. (Economics) from the London School of Economics and his LL.B. from the University of Toronto. Previously a partner of a major Canadian law firm, now merged into Borden Ladner Gervais, he serves as CEO of DeNovaStella AB, a Swedish start-up focussing on drug discovery and development in the field of pharmaceutically active plant-derived substances. Greg joined the Maas Biolab management team in February 2000 and is responsible for corporate and business development, finance, legal affairs, and project management.